Live courses

Titlesort descending Credit Cost Dates
Monthly Oncology Tumor Boards: Management of Non-Metastatic Prostate Cancer
    • 1.00 CCM clock hours
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
$0.00 07/06/2022 - 3:30pm to 4:30pm EDT
Monthly Oncology Tumor Boards: Management of Well-Differentiated Grade 3 Neuroendocrine Tumors
    • 1.00 CCM clock hours
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
$0.00 06/23/2022 - 3:00pm to 4:00pm EDT
Monthly Oncology Tumor Boards: Multidisciplinary Management of Localized Rectal Cancer
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
    • 1.00 CCM clock hours
    • 1.00 Participation
$0.00 05/31/2022 - 2:30pm to 3:30pm EDT
NCCN Pharmacy Updates: Navigating Advances in Targeted Therapies for Advanced Esophageal, Esophagogastric Junction (EGJ) and Gastric Cancers
    • 1.00 AAPA Category 1 CME credit
    • 1.00 ACPE contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
    • 1.00 Participation
$0.00 08/08/2022 - 11:00am to 12:00pm EDT
NCCN Pharmacy Updates: The Role of Tyrosine Kinase Inhibitors in Pediatric Acute Lymphoblastic Leukemia
    • 1.00 ANCC contact hours
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ACPE contact hours
    • 1.00 AAPA Category 1 CME credit
    • 1.00 Participation
$0.00 08/24/2022 - 1:30pm to 2:30pm EDT

Pages

Featured Online Courses

Titlesort descending Credit Type Event date Cost
Acute Myeloid Leukemia: Evidence-Based Guidance on Current Paradigms and New Therapeutic Approaches
    • 2.50 AAPA Category 1 CME credit
    • 2.50 ACPE contact hours
    • 2.50 AMA PRA Category 1 Credit™
    • 2.50 ANCC contact hours
    • 2.50 Participation
Enduring $0.00
Applying Guideline Updates and Real-World Experience in CLL: Experts Review State-of-the-Art Evidence and Address Clinical Challenges
    • 2.50 AAPA Category 1 CME credit
    • 2.50 ACPE contact hours
    • 2.50 AMA PRA Category 1 Credit™
    • 2.50 ANCC contact hours
    • 2.50 Participation
Enduring $0.00
Current and Emerging Systemic Therapies for Hepatocellular Carcinoma: Clinical Evidence and Guideline Recommendations
    • 1.50 AAPA Category 1 CME credit
    • 1.50 ACPE contact hours
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 ANCC contact hours
    • 1.50 Participation
Enduring $0.00
Current and Emerging Systemic Therapies for Renal Cell Carcinoma: Clinical Evidence and Guideline Recommendations
    • 1.50 AAPA Category 1 CME credit
    • 1.50 ACPE contact hours
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 ANCC contact hours
    • 1.50 Participation
Enduring $0.00
TARGET FOR NSCLC: The Advancing Research into Genomic Pathways and use of EGFR Therapies
    • 1.00 AAPA Category 1 CME credit
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC contact hours
    • 1.00 Participation
Enduring $0.00

Transcript

Please login or create an account to view your activities.

Pending Activities

Please login or create an account to view your activities.